Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
58 studies found for:    "narcolepsy"
Show Display Options
Rank Status Study
21 Recruiting Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Sleepiness
Interventions: Drug: JZP-110;   Drug: Placebo
22 Completed Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Condition: Narcolepsy
Intervention: Drug: Modafinil
23 Completed PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Narcolepsy;   Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
24 Enrolling by invitation "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
Conditions: Narcolepsy;   Obstructive Sleep Apnea
Intervention: Drug: JZP-110
25 Active, not recruiting A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
26 Completed Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Sodium Oxybate (Xyrem)
27 Recruiting A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Interventions: Drug: BTD-001;   Drug: Placebo
28 Recruiting Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Cataplexy;   Narcolepsy
Interventions: Drug: Sodium Oxybate;   Drug: Placebo
29 Recruiting Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Conditions: Narcolepsy With Cataplexy;   Narcolepsy Without Cataplexy
Interventions: Drug: pitolisant;   Drug: Placebo
30 Unknown  Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition
Condition: Narcolepsy
Intervention: Drug: Orexine A
31 Completed Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Condition: Narcolepsy
Intervention:
32 Recruiting The Effect of Caffeine on the Narcoleptic Patients
Condition: Narcolepsy
Interventions: Drug: Vivarin;   Drug: Fiber
33 Recruiting Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
Condition: Narcolepsy
Interventions: Drug: THN102 300/3;   Drug: THN102 300/27;   Drug: Modafinil 300
34 Completed Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)
Condition: Narcolepsy
Intervention: Drug: BF2.649
35 Completed A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
36 Completed
Has Results
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Intervention: Drug: Armodafinil
37 Completed Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Daytime Sleepiness;   Cataplexy;   Sleep Disorders
Interventions: Drug: BF2.649;   Drug: Modafinil;   Drug: Placebo
38 Completed A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
Condition: Narcolepsy, Excessive Daytime Sleepiness
Interventions: Drug: Placebo;   Drug: Sodium Oxybate;   Drug: JZP-386
39 Completed
Has Results
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions: Narcolepsy;   Sleep Apnea, Obstructive;   Sleep Apnea Syndromes;   Shift-Work Sleep Disorder
Intervention: Drug: CEP-10953 (Armodafinil)
40 Completed Single-dose Safety Study of APD916 in Healthy Volunteers
Condition: Narcolepsy With or Without Cataplexy
Intervention: Drug: APD916

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-58) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.